These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Potential pharmacokinetics interference between alpha-glucosidase inhibitors and other oral antidiabetic agents. Scheen AJ; Lefèbvre PJ Diabetes Care; 2002 Jan; 25(1):247-8. PubMed ID: 11772929 [No Abstract] [Full Text] [Related]
4. Alpha-glucosidase inhibition as an adjunct to the treatment of type 1 diabetes. Tattersall R Diabet Med; 1993 Oct; 10(8):688-93. PubMed ID: 8261749 [No Abstract] [Full Text] [Related]
5. Alpha-glucosidase inhibitors for type 2 diabetes mellitus. Van de Laar FA; Lucassen PL; Akkermans RP; Van de Lisdonk EH; Rutten GE; Van Weel C Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD003639. PubMed ID: 15846673 [TBL] [Abstract][Full Text] [Related]
6. [Current status of the treatment of type 2 diabetes mellitus. Alpha-glucosidase inhibitors]. Blicklé JF; Andres E; Brogard JM Rev Med Interne; 1999 Aug; 20 Suppl 3():379s-383s. PubMed ID: 10480189 [TBL] [Abstract][Full Text] [Related]
7. Miglitol and hepatotoxicity in type 2 diabetes mellitus. Carlson RF Am Fam Physician; 2000 Jul; 62(2):315, 318. PubMed ID: 10929699 [No Abstract] [Full Text] [Related]
8. [Pharmacokinetic, pharmacological, and clinical profile of miglitol (SEIBULE), a novel alpha-glucosidase inhibitor]. Kuboyama N; Hayashi I; Yamaguchi T Nihon Yakurigaku Zasshi; 2006 Mar; 127(3):223-32. PubMed ID: 16651808 [No Abstract] [Full Text] [Related]
9. Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus? Scheen AJ Drugs; 2003; 63(10):933-51. PubMed ID: 12699398 [TBL] [Abstract][Full Text] [Related]
10. Effect of alpha-inhibitors on blood glucose and insulin levels. Laube H; Federlin K; Hillebrand I Adv Exp Med Biol; 1988; 246():287-93. PubMed ID: 3074658 [No Abstract] [Full Text] [Related]
11. [Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy]. Kellerer M; Jakob S; Linn T; Haslbeck M MMW Fortschr Med; 2003 Dec; 145(51-52):I-X; quiz XI-XII. PubMed ID: 14974337 [No Abstract] [Full Text] [Related]
12. Potential of alpha-glucosidase inhibitors in elderly patients with diabetes mellitus and impaired glucose tolerance. Rabasa-Lhoret R; Chiasson JL Drugs Aging; 1998 Aug; 13(2):131-43. PubMed ID: 9739502 [TBL] [Abstract][Full Text] [Related]
13. [Alpha-glucosidase inhibitor in type 2 diabetic patients. Metabolism and body weight are favorably modified]. Fehmann HC MMW Fortschr Med; 2001 Apr; 143(17):46. PubMed ID: 11490509 [No Abstract] [Full Text] [Related]
18. A new era in type 2 diabetes mellitus treatment? Laws A Am J Med; 2001 Jul; 111(1):71-2. PubMed ID: 11448665 [No Abstract] [Full Text] [Related]
19. Miglitol, a new alpha-glucosidase inhibitor. Sels JP; Huijberts MS; Wolffenbuttel BH Expert Opin Pharmacother; 1999 Nov; 1(1):149-56. PubMed ID: 11249557 [TBL] [Abstract][Full Text] [Related]
20. Does suppression of postprandial blood glucose excursions by the alpha-glucosidase inhibitor miglitol improve insulin sensitivity in diet-treated type II diabetic patients? Johnson AB; Taylor R Diabetes Care; 1996 Jun; 19(6):559-63. PubMed ID: 8725851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]